Crossmark

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4048-8

Published Online: 2018-02-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martinez-Useros, J.

Moreno, I.

Fernandez-Aceñero, M. J.

Rodriguez-Remirez, M.

Borrero-Palacios, A.

Cebrian, A.

Gomez del Pulgar, T.

del Puerto-Nevado, L.

Li, W.

Puime-Otin, A.

Perez, N.

Soengas, M. S.

Garcia-Foncillas, J.
Funding

Funding for this research was provided by:

RNA-Reg CONSOLIDER Network (CSD2009-00080)

Instituto de Salud Carlos III-FEDER (PI16/01468)
More Information

Article History

Received: 9 May 2016

Accepted: 24 January 2018

First Online: 6 February 2018

Ethics approval and consent to participate

: The clinical samples used in the study were kindly supplied by the BioBank of the Fundacion Jimenez Diaz – Universidad Autonoma de Madrid (PT13/0010/0012). All patients gave written informed consent for the use of their biological samples for research purposes. The institutional review board (IRB) of the Fundacion Jimenez Diaz Hospital evaluated the study, granting approval on December 9, 2014 under approval number 17/14. The FJD-IRB also certified that this study belongs to the RNA-Reg Consolider-Ingenio Network (CSD2009–0080) and Spanish Health Research Project Funds (PI16/01468) fromInstituto de Salud Carlos III(ISCIII)-Fondos FEDER.

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.